European Archives - Page 310 of 1006 - European Medical Journal

Editor’s Pick – Utility of Bedside Lung Ultrasound in Patients on Chronic Haemodialysis

Estimation of reliable and reproducible dry weight in patients with end-stage renal disease on haemodialysis (HD) is a clinical challenge to date.

Benzodiazepines in Dementia: Review of Clinical Evidence

In the Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5), Alzheimer’s disease (AD [named after the German psychiatrist and neuropathologist, Alois Alzheimer, who first described it]), is considered as a major or mild neuro-cognitive disorder…

Engineering the Future of Surgery

Monica Jain and Jonathan discuss innovation and biomedical engineering in healthcare and surgery.

EMJ Cardiology 11 [Supplement 1] 2023

Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.

Hearts are NOT Made to Be Broken: Expert Opinion on Amyloid Light-Chain Cardiac Amyloidosis

Amyloid light-chain (AL) amyloidosis is a rare systemic disease caused by plasma cell dyscrasia. These plasma cells produce excess Ig light chains, which can misfold, aggregate, and deposit in tissues, resulting in toxicity and organ dysfunction. The heart is among the most commonly affected organs and cardiac involvement is associated with significantly worse outcomes.

Upgrading the personal touch in CX

Pharma’s approach to customer experience could be improved with humanisation of digital touchpoints.

Incidence of Chronic Pelvic Pain in Females Attending a Gynaecology Outpatient Department

Chronic pelvic pain (CPP) affects up to 25% of females of reproductive age, and 15% of all females worldwide. It is a common complaint of females visiting the gynaecology outpatient department.

Inspiring change in obesity treatment

Novo Nordisk’s new obesity drug could be set to transform obesity care, but there’s much more that pharma can do to help.

GSK's Judy Stewart on vaccine preventable diseases

GSK’s Judy Stewart discusses her ambition to work in pharmaceuticals and make a difference to public health, the vast GSK vaccine pipeline, leadership and the importance of work-life balance.

EMJ Hematology 11 [Supplement 1] 2023

Gene therapy for haemophilia A and B was discussed during several sessions at the 64th American Society of Hematology (ASH) Annual Meeting, held 10th–13th December 2022.